The Vanguard Group 13D/13G Filings for OptimizeRx Corporation (OPRX)

The Vanguard Group 13D and 13G filings for OptimizeRx Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-13
5:12 pm
Sale
2023-12-29 13G OptimizeRx Corporation
OPRX
The Vanguard Group 1,021,002
5.620%
-90,409decrease
(-8.13%)
Filing
2023-02-09
11:27 am
Purchase
2022-12-30 13G OptimizeRx Corporation
OPRX
The Vanguard Group 1,111,411
6.480%
28,635increase
(+2.64%)
Filing
2022-02-10
08:28 am
Purchase
2021-12-31 13G OptimizeRx Corporation
OPRX
The Vanguard Group 1,082,776
6.090%
1,082,776increase
(New Position)
Filing